Saneron CCEL Therapeutics

Saneron CCEL Therapeutics is a clinical-stage biotechnology company specializing in the development of cell-based therapies for neurological and cardiovascular disorders. The company's proprietary U-CORD-CELL platform utilizes umbilical cord blood-derived cells, which are ethically sourced and non-invasive, to promote tissue repair and neuroprotection. Saneron's lead programs are focused on treating Amyotrophic Lateral Sclerosis (ALS) and stroke, with additional research into Alzheimer's and Parkinson's diseases. Based in Tampa, Florida, the company operates in close collaboration with the University of South Florida to advance its regenerative medicine pipeline. Their therapeutic approach aims to address the underlying pathology of neurodegenerative conditions through cellular replacement and the secretion of trophic factors.